Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
1467052-75-0
Purity
95%
Tazemetostat is a methyltransferase inhibitor indicated to treat patients 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection.
Properties
Name
Tazemetostat hydrobromide
Smiles
Br.CCN(C1CCOCC1)C=2C=C(C=C(C(=O)NCC3=C(C)C=C(C)NC3=O)C2C)C=4C=CC(CN5CCOCC5)=CC4
Targets
Please log in to see this information
SDS
E7438 | EPZ-6438 | tazemetostat | tazverik
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$53
2 mg
$54
5 mg
$55
10 mg
$66
15 mg
$73
20 mg
$81
25 mg
$90
30 mg
$100
35 mg
$108
40 mg
$116
45 mg
$122
50 mg
$136
75 mg
$208
100 mg
$238
Quantity
1
Total amount
$ 55
E7438 | EPZ-6438 | tazemetostat | tazverik
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.
CAS:1403254-99-8
0